Sandford Frederick J 4
4 · Sonoma Pharmaceuticals, Inc. · Filed Jan 11, 2019
Insider Transaction Report
Form 4
Sandford Frederick J
DirectorCEO and Interim CFO
Transactions
- Award
Stock option (right to buy)
2019-01-10+400,000→ 400,000 totalExercise: $0.72From: 2019-07-10Exp: 2029-01-10→ Common Stock (400,000 underlying) - Award
Stock option (right to buy)
2019-01-10+50,000→ 450,000 totalExercise: $0.72From: 2019-07-10Exp: 2029-01-10→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The options were granted to Mr. Sandford as an inducement stock option award in accordance with Nasdaq Listing Rule 5635(c)(4), as an inducement material to his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer.
- [F2]The options were granted to Mr. Sandford for his entering into employment with the Issuer as Chief Executive Officer and Interim Chief Financial Officer.